Clinical Trial Highlights

• PROMISE
• Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies
• Continued Dual Antiplatelet Therapy Beneficial in PEGASUS-TIMI 54 and DAPT Trials
• MATRIX
• Evolocumab Effectively Lowers LDL-C, Decreases Cardiovascular Outcomes in OSLER
• EMBRACE
• REGULATE-PCI Trial
• SCOT-HEART
• SAPIEN 3 TAVR System Produces Excellent Clinical Outcomes in PARTNER II Trial
• BEST Trial
• Ablation for Mitral Valve Patients With AF Successfully Controls Heart Rhythm
• TOTAL
• NOTION Trial
• Ezetimibe Plus Simvastatin More Beneficial Than Simvastatin Alone in Reducing Recurrent Cardiovascular Events
• LEGACY
• After Eighty Study